GLP-1 mimetics re-sensitize insulin signaling in the brains of animal models of AD (Bomfim et al., 2012; Long-Smith et al., 2013; Shi et al., 2017) and in patients with T2DM (Zander et al., 2002). Here, GCG is linked to Alzheimer disease.